Indolent systemic mastocytosis (ISM) is one of the five subtypes of systemic mastocytosis, a condition characterized by the ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In a study of 116 patients with systemic mastocytosis (SM), a rare mast cell disease, about 1 in 5 participants ...

Cogent Biosciences, Inc. topline results for phase 2/3 studies on bezuclastinib targeting systemic mastocytosis & GIST are ...

Because of the often nonspecific nature of MCL, diagnostic efforts need to be better streamlined to reduce the risk of misdiagnosis.

Blueprint Medicines Corporation focuses on Ayvakit, BLU-808, and Elenestinib with strong potential in mast cell disorders.

Healthcare Analysts provide expert insights on current and emerging treatments for Systemic Mastocytosis (relevant companies Blueprint ...

Joan Smith spent almost 40 years believing she suffered from severe allergies. Medical professionals frequently dismissed her concerns until a concerning episode made her seek out more answers.

Gastrocrom is used to treat mastocytosis in adults and in children ages 2 years and older. Note: Most of the side effects Gastrocrom can cause are also symptoms of mastocytosis, which Gastrocrom ...

In a study of 116 patients with systemic mastocytosis (SM), a rare mast cell disease, about 1 in 5 participants progressed to an advanced form of SM, incurring greater healthcare costs along the way.